عناصر مشابهة
Calprotectin as a Method of Screening for Irritable Bowel Syndrome
| المصدر: | المجلة العربية للنشر العلمي |
|---|---|
| الناشر: |
مركز البحث وتطوير الموارد البشرية - رماح
|
| المؤلف الرئيسي: | |
| مؤلفين آخرين: | , |
| المجلد/العدد: | ع55 |
| محكمة: | نعم |
| الدولة: | الأردن |
| التاريخ الميلادي: | 2023 |
| الصفحات: | 29 - 34 |
| ISSN: | 2663-5798 |
| رقم MD: | 1437521 |
| نوع المحتوى: | بحوث ومقالات |
| اللغة: | English |
| قواعد المعلومات: | EduSearch HumanIndex |
| مواضيع: | |
| رابط المحتوى: |
|
| المستخلص: | Irritable bowel Syndrome (IBS) is a very common functional digestive disorder which affects 10-15% of the population. It mainly affects young and middle-aged adults, especially in western industrial societies. The main symptoms consist of cramps, bloating and bowel motion alterations. Although it is a benign digestive disorder, investigations to rule out organic digestive disease are of utmost importance, and for that reason having a sensible maker or investigation is very important to avoid invasive, complicated or expensive procedures. Calprotectin, a protein biomarker which is present in human faeces during gastrointestinal inflammatory processes, has shown promise as a good method to rule out inflammatory digestive disease. Investigating calprotectin levels may therefore be a cheap and effective method for distinguishing inflammatory from non-inflammatory Bowel diseases. Therefore, the purpose of this scoping review is to compile the most recent evidence on the use of calprotectin levels in general practice. |
|---|
